Bio-Rad Laboratories (BIO) Retained Earnings (2009 - 2026)

Bio-Rad Laboratories (BIO) has reported Retained Earnings for 18 consecutive years, with $8.0 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Retained Earnings rose 2.85% year-over-year to $8.0 billion in Q2 2026; TTM through Jun 2026 was $8.0 billion, a 2.85% increase from a year earlier, with the FY2025 full-year figure at $8.2 billion, up 10.25% from the prior year.
• Retained Earnings was $8.0 billion for Q2 2026 at Bio-Rad Laboratories, up from $7.6 billion in the prior quarter.
• Over five years, Retained Earnings peaked at $10.1 billion in Q1 2022 and troughed at $7.4 billion in Q4 2024.
• A 5-year average of $8.6 billion and a median of $8.5 billion in 2023 frame the typical range for Retained Earnings.
• Across the five-year window, Retained Earnings sank 40.01% in 2022 and climbed 10.25% in 2025, its largest moves.
• Over 5 years, Retained Earnings stood at $9.9 billion in 2022, then retreated by 6.44% to $9.3 billion in 2023, then declined by 19.91% to $7.4 billion in 2024, then gained by 10.25% to $8.2 billion in 2025, then dropped by 1.9% to $8.0 billion in 2026.
• The last three Retained Earnings figures came in at $8.0 billion (Q2 2026), $7.6 billion (Q1 2026), and $8.2 billion (Q4 2025), per Business Quant data.